| Erica Alexis Johnson, | |
|
3300 Gallows Rd, Falls Church, VA 22042-3307 | |
| (703) 776-4001 | |
| Not Available |
| Full Name | Erica Alexis Johnson |
|---|---|
| Gender | Female |
| Speciality | Surgery |
| Location | 3300 Gallows Rd, Falls Church, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578230652 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 0116036657 (Virginia) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Erica Alexis Johnson, 3405 Philips Dr, Pikesville, MD 21208-1827 Ph: (443) 929-0853 | Erica Alexis Johnson, 3300 Gallows Rd, Falls Church, VA 22042-3307 Ph: (703) 776-4001 |
News Archive
The level of HIV-1 in the blood of an HIV-infected partner is the single most important factor influencing risk of sexual transmission to an uninfected partner, according to a multinational study of heterosexual couples in sub-Saharan Africa.
In the largest randomized controlled trial of treatment for high blood pressure ever conducted in sub-Saharan Africa, two frontline two-drug combinations that included the long-acting calcium channel blocker, amlodipine, were able to drive down blood pressure levels more than a third two-drug combination that did not include amlodipine, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.
Medivir AB today announced a non-exclusive collaboration between Janssen Pharmaceuticals Inc. (Janssen) and Idenix Pharmaceuticals for the clinical development of an all-oral (interferon-free) direct-acting antiviral (DAA) hepatitis C (HCV) combination therapy.
New research from scientists at Huntsman Cancer Institute at the University of Utah and collaborators at University of Utah Health sheds light on the complex process that occurs in the development of human sperm stem cells.
Omeros Corporation today announced that the National Institute on Drug Abuse (NIDA) has provided an additional grant to fund clinical studies for the Company's Addiction program. This grant, which is for a total of approximately $3.6 million to be paid over a four-year period in equal amounts, will fund direct and indirect costs of Phase 2 clinical studies to be conducted by researchers at the New York State Psychiatric Institute.
› Verified 2 days ago
Richard Francis Neville, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-7113 | |
Nicholas Rolle, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 | |
Quoc-hung Ly Nguyen, MD Surgery Medicare: Medicare Enrolled Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-7113 | |
Dr. Maura Morgan, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-988-6912 | |
Dr. David Paul Blake, MD, MPH Surgery Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-531-2246 Fax: 703-237-7895 | |
Michael J Weyant, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-7113 | |
Ahmad Safra, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-8043 Fax: 703-208-6654 |